Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01359215 · ClinicalTrials.gov registry record
Childhood Anesthesia and Cognitive Function
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 30
- Enrollment target
NCT01359215: Completed study, sponsored by University of California, San Francisco.
NCT01359215 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01359215 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether pediatric anesthesia is associated with long-term hippocampal dysfunction
Primary Outcome
Subjects who received and anesthetic during the first two years of life and controls are given a cognitive test at 6 to 12 years of age
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-05 |
What the finished NCT01359215 record still lists
NCT01359215 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01359215 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01359215 about?
NCT01359215 is a clinical study titled "Childhood Anesthesia and Cognitive Function". The purpose of this study is to determine whether pediatric anesthesia is associated with long-term hippocampal dysfunction
What is the current status of trial NCT01359215?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2011-03. Estimated completion is 2012-05.
Who is sponsoring clinical trial NCT01359215?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia